Nafamostat Mesylate Versus Regional Citrate Anticoagulation for Continuous Renal Replacement Therapy in Sepsis-Associated Acute Kidney Injury
Conditions
- Sepsis
- Acute Kidney Injury
- Continuous Renal Replacement Therapy (CRRT)
Interventions
- DRUG: Citrate anticoagulation
- DRUG: Nafamostat Mesylate
Sponsor
Jianfeng Xie
Collaborators